ruse
aav
dependoviru
genu
recent
addit
human
parvovirus
discov
detect
largescal
screen
exogen
dna
rna
sequenc
panel
blood
sampl
individu
acut
infect
undiagnos
etiolog
resembl
known
mammalian
parvovirus
probabl
classifi
sole
member
new
parvoviru
genu
time
second
novel
human
parvoviru
discov
pool
respiratori
sampl
viru
name
human
bocaviru
hbov
sinc
close
relat
parvovirus
bovin
parvoviru
minut
canin
viru
bocaviru
genu
ie
bovinecanin
parvovirida
hbov
infect
found
wide
distribut
among
young
children
worldwid
grow
evid
etiolog
role
sever
lower
respiratori
tract
infect
contrast
detect
infect
date
confin
origin
infect
studi
subject
occasion
pool
plasma
sampl
use
bloodproduct
manufactur
thu
preval
epidemiolog
transmiss
rout
clinic
associ
remain
undetermin
basi
observ
rel
shortliv
viremia
develop
strong
immun
respons
confer
protect
reinfect
infect
consid
acut
spontan
resolv
howev
recent
evid
tissu
biopsi
specimen
autopsi
sampl
indic
frequent
persist
infect
previous
expos
individu
even
though
infect
control
effect
immun
system
extent
persist
viremia
infrequ
invari
low
titer
among
seroposit
individu
combin
longterm
persist
immun
reinfect
shown
creat
socal
bioportfolio
possibl
persist
dna
virus
aav
encount
earli
life
may
preserv
lifelong
thu
constitut
record
viru
variant
circul
sever
decad
previous
current
studi
examin
seri
sampl
differ
tissu
collect
autopsi
presenc
hbov
dna
sequenc
compar
frequenc
detect
viral
load
genet
variabl
sampl
hivinfect
individu
aid
hereaft
refer
preaid
studi
subject
termin
aid
time
death
compar
correspond
sampl
hivuninfect
individu
investig
relationship
viral
load
immunosuppress
thu
role
immun
system
control
viru
replic
bone
marrow
lymphoid
tissu
brain
tissu
examin
part
initi
investig
cellular
tropism
differ
parvovirus
vivo
autopsi
tissu
sampl
use
project
obtain
edinburgh
medic
research
council
hiv
brain
tissu
bank
western
gener
hospit
edinburgh
consent
use
postmortem
tissu
obtain
lothian
research
ethic
committe
studi
viral
load
autopsi
tissu
lymphoid
lymph
node
spleen
brain
frontal
occipit
lobe
bone
marrow
tissu
sampl
obtain
hivinfect
individu
aid
time
death
hivinfect
individu
without
aid
hivuninfect
individu
tabl
sampl
store
use
subsequ
polymeras
chain
reaction
pcr
analys
studi
subject
aid
untreat
antiretrovir
drug
death
preaid
studi
subject
count
cellsml
time
death
except
studi
subject
count
cellsml
presymptomat
studi
subject
die
aidsunrel
caus
plasma
sampl
obtain
total
previous
untreat
individu
vari
stage
diseas
progress
reflect
lymphocyt
count
tabl
plasma
sampl
obtain
lowrisk
hivneg
individu
approxim
age
match
hivposit
individu
sampl
collect
period
time
dna
extract
tissu
sampl
extract
describ
elsewher
extract
dna
quantifi
spectrophotometri
nm
maximum
mg
dna
assay
pcr
dna
extract
volum
plasma
use
qiaamp
dna
blood
minikit
qiagen
extract
dna
resuspend
ml
elut
buffer
ml
assay
pcr
amplif
parvoviru
hbov
dna
sequenc
nestedpcr
method
use
amplif
hbov
dna
primer
base
highli
conserv
region
ns
gene
follow
sequenc
posit
base
sequenc
parenthes
outer
sens
gtgtatcagcaatttgtrsaatt
inner
sens
tytgtttgacttagttgctcg
inner
antisens
actggrtgataaggcatgggg
outer
antisens
taagtcttcactagataatac
screen
hbov
dna
use
previous
describ
primer
sequenc
ns
gene
share
amplif
protocol
target
use
nest
pcr
viru
target
sensit
singl
copi
target
sequenc
enabl
use
limit
dilut
quantit
posit
sampl
autopsi
sampl
initi
screen
perform
use
mg
dna
sampl
posit
sampl
titrat
dilut
step
limit
dilut
observ
replic
reaction
viral
load
calcul
frequenc
posit
reaction
limit
dilut
express
copi
per
million
cell
plasma
sampl
screen
sequenc
mean
pcr
use
ml
extract
dna
ml
origin
sampl
base
singlecopi
detect
assay
theoret
sensit
dna
copiesml
plasma
rule
presenc
impur
extract
dna
could
reduc
pcr
sensit
quantiti
extract
dna
differ
autopsi
tissu
volum
differ
plasma
sampl
amplifi
reaction
spike
copi
dna
inhibit
amplif
detect
sampl
compar
amplif
control
nucleotid
sequenc
sampl
sequenc
region
amplifi
screen
primer
use
big
dye
termin
kit
appli
biosystem
amplicon
obtain
screen
short
sequenc
use
follow
altern
set
primer
ns
gene
outer
sens
gugguaaraaaaayacmcugugg
inner
sens
suguuccaguruauggcaugg
inner
antisens
aaguaaugucaccauugcugg
outer
antisens
guaascccaugucagggcugcauc
sampl
posit
screen
primer
abl
amplifi
sequenc
primer
access
number
nucleotid
sequenc
obtain
studi
submit
genbank
assign
access
number
detect
parvovirus
autopsi
tissu
dna
sampl
extract
lymphoid
tissu
lymph
node
spleen
depend
avail
bone
marrow
sampl
brain
tissu
cerebr
cortex
screen
parvoviru
dna
mean
nest
pcr
use
set
hbov
primer
tabl
dna
frequent
detect
studi
subject
categori
hiv
neg
preaid
aid
wherea
dna
detect
studi
subject
hiv
coinfect
preaid
studi
subject
studi
subject
aid
contrast
frequent
detect
parv
sequenc
hbov
dna
detect
studi
subject
previous
describ
associ
hbov
respiratori
infect
also
assay
autopsi
lung
sampl
studi
subject
aid
pcr
analysi
show
sampl
neg
hbov
dna
data
shown
sampl
posit
dna
quantifi
limitingdilut
pcr
figur
viral
load
vari
wide
within
tissuesampl
type
subject
categori
rang
undetect
dna
cell
sever
sampl
copi
cell
data
subject
categori
combin
highest
viral
load
found
bone
marrow
sampl
median
level
dna
cell
versu
dna
cell
lymphoid
tissu
mannwhitney
nonparametr
u
p
p
test
dna
cell
brain
tissu
p
p
figur
among
hivinfect
studi
subject
similar
differ
found
viral
load
bone
marrow
versu
lymphoid
tissu
median
valu
dna
cell
respect
figur
p
p
neither
show
associ
increas
viral
load
immunosuppress
figur
median
viral
load
hivuninfect
individu
rang
valu
similar
preaid
aid
subject
categori
eg
median
viral
load
lymphoid
tissu
hiv
uninfect
individu
dna
cell
compar
dna
cell
preaid
studi
subject
aid
respect
among
hivp
infect
studi
subject
correl
lymphocyt
count
viral
load
found
tissu
examin
determin
mean
nonparametr
spearman
rank
correl
test
use
previous
r
p
determin
hiv
viral
load
subject
studi
group
also
found
associ
extent
infect
extent
hiv
infect
tissu
examin
r
p
although
found
lymphoid
tissu
bone
marrow
hivinfect
individu
correl
immunosuppress
viral
load
viral
load
similar
preaid
studi
subject
aid
figur
tabl
individu
studi
group
demograph
similar
hivposit
studi
subject
autopsi
sampl
obtain
also
show
rang
lymphocyt
count
substanti
overlap
latter
group
tabl
given
likelihood
substanti
proport
test
individu
persist
infect
neg
find
analysi
plasma
sampl
indic
persist
infect
either
viru
associ
frequent
viremia
genotyp
amplifi
dna
sampl
posit
sequenc
identifi
genotyp
infect
studi
subject
figur
among
hivinfect
uninfect
studi
subject
sequenc
genotyp
detect
studi
subject
respect
significantli
differ
age
distribut
genotyp
figur
median
year
birth
genotyp
studi
subject
significantli
later
genotyp
studi
subject
vs
respect
genotyp
sequenc
differ
p
p
genotyp
sequenc
region
sequenc
posit
ns
region
prototyp
sequenc
show
highli
constrain
pattern
variabl
substitut
within
genotyp
confin
synonym
site
ie
nonamino
acid
chang
pattern
sequenc
variabl
among
sequenc
remark
similar
sequenc
two
variant
detect
differ
region
sequenc
posit
complet
parv
genom
sequenc
substitut
confin
synonym
site
fourteen
sequenc
ident
refer
genotyp
remain
provision
term
genotyp
show
greater
intragroup
variabl
mean
pairwis
distanc
genotyp
infect
found
born
median
year
birth
compar
genotyp
infect
figur
p
p
indic
frequent
detect
autopsi
tissu
show
evid
lifelong
persist
infect
contrast
markedli
find
hbov
high
frequenc
detect
studi
consist
previou
pcrbase
evid
frequent
potenti
lifelong
persist
infect
strong
cytotox
cell
reactiv
among
seroposit
individu
appear
subclass
antibodi
usual
associ
chronic
viral
infect
inde
ongo
immunoreact
site
replic
potenti
etiolog
role
sever
chronic
inflammatori
diseas
arthriti
although
high
frequenc
detect
also
report
varieti
tissu
synovium
liver
bone
marrow
myocardium
lymphoid
tissu
studi
subject
without
inflammatori
diseas
indic
result
current
studi
persist
may
usual
outcom
infect
detect
may
incident
inflammatori
diseas
sinc
high
frequenc
infect
detect
lymphoid
cell
previou
studi
figur
higher
viral
load
inflam
tissu
synovi
tissu
subject
arthriti
may
arisen
migrat
inflammatori
cell
affect
tissu
although
highest
viral
load
detect
bone
marrow
consist
propens
parvovirus
target
divid
cell
found
lymphoid
tissu
detect
brain
autopsi
sampl
spread
central
nervou
system
cn
occur
studi
subject
relat
immunosuppress
figur
find
consist
frequent
detect
dna
sequenc
prefront
cortex
sampl
recent
studi
detect
dna
sequenc
autopsi
brain
sampl
unlik
simpli
spillov
effect
associ
entri
lymphoid
stem
cell
cn
viral
load
similar
lymphoid
bone
marrowderiv
cell
consist
absent
brain
sampl
tabl
surpris
find
current
studi
similar
viral
load
immunocompet
immunosuppress
individu
figur
despit
destruct
immun
system
patient
termin
aid
replic
remain
tight
control
evid
increas
viral
load
autopsi
tissu
studi
subject
aid
compar
preaid
hivuninfect
individu
viremia
undetect
larger
studi
popul
individu
includ
sever
low
lymphocyt
count
behavior
contrast
markedli
persist
dna
virus
human
cytomegaloviru
reactiv
lead
clinic
signific
diseas
frequent
develop
aid
anoth
exampl
ubiquit
distribut
persist
small
dna
viru
torquetenoviru
ttv
also
show
evid
increas
viral
replic
immunosuppress
individu
use
autopsi
sampl
analyz
current
studi
increas
ttv
viral
load
found
bone
marrow
lymphoid
tissu
brain
tissu
sampl
studi
subject
aid
compar
sampl
preaid
hivuninfect
studi
subject
j
willey
g
j
hugh
luca
j
e
bell
p
simmond
unpublish
data
dna
sequenc
detect
studi
subject
categori
detect
dna
confin
hivinfect
individu
tabl
three
hypothes
might
explain
restrict
distribut
possibl
immunocompet
individu
immun
system
control
replic
extent
dna
becom
undetect
autopsi
sampl
wherea
reactiv
occur
immunosuppress
individu
hiv
infect
altern
infect
may
nonpersist
immunocompet
individu
preaid
studi
subject
aid
current
studi
may
develop
persist
infect
reexposur
infect
hiv
final
possibl
exposur
infect
restrict
hivinfect
group
share
rout
transmiss
sexual
contact
parenter
exposur
latter
possibl
support
find
histori
injectiondrug
use
studi
subject
without
antibodi
assay
current
difficult
distinguish
hypothes
howev
replic
control
immun
system
way
similar
way
replic
sever
observ
current
studi
point
toward
third
hypothesi
first
evid
measur
viral
load
preaid
studi
subject
aid
indic
degre
immunosuppress
effect
viral
replic
figur
lack
detect
hivuninfect
individu
result
immun
control
viral
load
would
expect
much
lower
preaid
group
sinc
retain
modestli
function
immun
system
compar
studi
subject
aid
second
clear
differenti
infect
statu
concord
result
obtain
lymphoid
bone
marrow
sampl
individu
similarli
distinct
distribut
viral
load
among
infect
individu
neg
sampl
figur
infect
vari
degre
immun
control
differ
stage
hiv
diseas
progress
clear
differenti
hivinfect
uninfect
individu
would
unlik
futur
investig
autopsi
sampl
hivinfect
individu
noninjectiondrug
user
idu
hivuninfect
idu
help
resolv
underli
reason
associ
infect
hiv
infect
current
studi
understand
epidemiolog
transmiss
pattern
advanc
greatli
owe
discoveri
tempor
success
infect
genotyp
past
year
well
recent
evid
much
higher
rate
sequenc
chang
parvovirus
thought
previous
find
significantli
older
age
distribut
among
studi
subject
infect
genotyp
close
reproduc
find
finnish
studi
demonstr
variant
detect
biopsi
sampl
correspond
origin
infect
strain
observ
disappear
genotyp
infect
individu
born
close
match
data
current
studi
last
genotyp
infect
detect
individu
born
figur
similar
provid
evid
longrang
transmiss
network
quit
distantli
separ
countri
northern
europ
evid
obtain
equival
tempor
success
infect
differ
genotyp
studi
group
infect
diverg
variant
provision
refer
genotyp
current
studi
correspond
previous
describ
variant
restrict
studi
subject
born
earlier
age
rang
even
sharpli
differenti
genotyp
compar
differ
observ
genotyp
infect
associ
needl
share
hiv
infect
discuss
previou
subsect
time
scale
success
would
substanti
recent
thu
infect
might
occur
first
case
hiv
infect
occur
edinburgh
hypothesi
recent
sourc
infect
risk
group
support
nucleotidesequ
divers
sequenc
variat
observ
genotyp
sequenc
bp
recent
describ
high
rate
sequenc
chang
canin
parvoviru
use
infer
maximum
time
sinc
diverg
variant
base
assumpt
substitut
rate
synonym
site
viral
nonstructur
region
similar
differ
genera
parvovirida
applic
observ
mean
substitut
rate
substitut
per
site
per
year
percentil
rang
substitut
variant
infect
studi
subject
well
individu
origin
discov
would
diverg
within
last
year
rang
year
death
predict
indic
recent
introduct
rapid
dissemin
infect
hividu
risk
group
edinburgh
contrast
calcul
appli
genotyp
variant
studi
subject
mean
pairwis
distanc
predict
earlier
averag
diverg
time
year
remark
consist
observ
replac
genotyp
genotyp
figur
rapid
turnov
chang
transmiss
dynam
genet
variant
reveal
new
model
parvoviru
evolut
may
appli
broadli
member
parvovirida
combin
set
publish
sequenc
gene
hbov
sequenc
includ
geograph
dispar
sourc
sweden
canada
japan
australia
show
mean
pairwis
distanc
correspond
predict
time
origin
year
rang
year
intrigu
altern
hypothesi
hbov
detect
autopsi
sampl
infect
nonpersist
see
genet
data
support
possibl
hbov
also
might
spread
scotland
recent
circul
childhood
year
studi
subject
hbov
infect
usual
seem
acquir
studi
includ
develop
serolog
assay
antibodi
hbov
clearli
requir
order
understand
fulli
transmiss
dynam
persist
hbov
infect
